HDL-C水平及其变异性与糖尿病风险:全国人群研究
该研究基于韩国国民健康保险系统约511万无糖尿病成人,计算访视间HDL-C变异性,中位随访5.1年。结果显示HDL-C均值低或变异性高均与糖尿病风险升高相关,二者存在叠加效应。
要点
- HDL-C均值低与变异性高均为糖尿病的独立预测因素
- 两项指标同时异常时糖尿病风险叠加升高
- 升高并稳定HDL-C可能是降低糖尿病风险的重要目标
核心结论
- HDL-C均值低和高变异性是糖尿病的独立预测因素,且具有叠加效应。
研究设计与样本
- 基于韩国国民健康保险系统的全国性人群队列研究,纳入2009至2013年间接受三次及以上健康体检、基线无已知糖尿病的5,114,735名成人。
主要发现
- 中位随访5.1年间新发糖尿病122,192例(2.4%)。
- HDL-C均值越低或变异性越高,糖尿病风险呈阶梯式升高,两项指标存在叠加效应。
- 多变量校正模型中,以高均值/低VIM组为参照,高均值/高VIM组HR为1.20(95%CI 1.18至1.22),低均值/低VIM组为1.35(95%CI 1.33至1.37),低均值/高VIM组为1.40(95%CI 1.38至1.42)。
- 以CV建模变异性及多项亚组分析结果相似。
关键数值与推荐
- HDL-C低均值组和高变异性组分别定义为HDL-C均值与变异性的最低和最高四分位。
- 变异性采用不依赖均值的变异性(VIM)和变异系数(CV)计算。
临床怎么用
- 临床评估糖尿病风险时,除关注HDL-C水平外,还应关注其访视间变异性。
- 对HDL-C偏低且波动较大者,可视为糖尿病高风险人群加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The bidirectional relationship between low high-density lipoprotein cholesterol (HDL-C) and glucose intolerance is well established. Recent studies suggested an association of lipid variability with various health outcomes. OBJECTIVE: To investigate the combined effect of HDL-C levels and their variability on the risk of diabetes. DESIGN: A population-based cohort study. SETTING AND PARTICIPANTS: In all, 5,114,735 adults without known diabetes in the Korean National Health Insurance System cohort who underwent three or more health examinations from 2009 to 2013 were included. Visit-to-visit HDL-C variability was calculated using variability independent of the mean (VIM) and the coefficient of variation (CV). Low mean and high variability groups were defined as the lowest and highest quartiles of HDL-C mean and variability, respectively. MAIN OUTCOME MEASURES: Newly developed diabetes. RESULTS: There were 122,192 cases (2.4%) of incident diabetes during the median follow-up of 5.1 years. Lower mean or higher variability of HDL-C was associated with higher risk of diabetes in a stepwise manner, and an additive effect of the two measures was noted. In the multivariable-adjusted model, the hazard ratios and 95% CIs for incident diabetes were 1.20 (1.18 to 1.22) in the high mean/high VIM group, 1.35 (1.33 to 1.37) in the low mean/low VIM group, and 1.40 (1.38 to 1.42) in the low mean/high VIM group compared with the high mean/low VIM group. Similar results were observed when modeling the variability using CV and in various subgroup analyses. CONCLUSIONS: Low mean and high variability in HDL-C were independent predictors of diabetes with an additive effect. Both elevating and stabilizing HDL-C may be important goals for reducing diabetes risk.
引用
- Lee SH, Kim HS, Park YM, et al. HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study. J Clin Endocrinol Metab. 2019. PMID: 31408161. doi:10.1210/jc.2019-01080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。